Dapagliflozin in Non Alcoholic Fatty Liver Disease Associated Cirrhosis and Its Role in Preventing Development of Chronic Kidney Disease.
Condition: NAFLD Cirrhosis Interventions: Drug: Dapagliflozin; Other: Standard of Care Sponsor: Institute of Liver and Biliary Sciences, India Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials